Cancer Genetics and Epigenetics 2024, Vol.12, No.1, 47-54 http://www.medscipublisher.com/index.php/cge 53 International Human Genome Sequencing Consortium, 2001, Initial sequencing and analysis of the human genome, Nature, 409: 860-921. Jung I., An J., and Ko M., 2023, Epigenetic regulators of DNA cytosine modification: promising targets for cancer therapy, Biomedicines, 11(3): 654. https://doi.org/10.3390/biomedicines11030654 PMid:36979633 PMCid:PMC10045866 Koowattanasuchat S., Ngernpimai S., Matulakul P., Thonghlueng J., Phanchai W., Chompoosor A., Panitanarak U., Wanna Y., Intharah T., Chootawiriyasakul K., Anata P., Chaimnee P., Thanan R., Sakonsinsiri C., and Puangmali T., 2023, Rapid detection of cancer DNA in human blood using cysteamine-capped AuNPs and a machine learning-enabled smartphone, RSC Advances, 13: 1301-1311. https://doi.org/10.1039/D2RA05725E PMid:36686949 PMCid:PMC9814906 Lin J., and Ngiam K., 2023, How data science and AI-based technologies impact genomics, Singapore Medical Journal, 64: 59-66. https://doi.org/10.4103/singaporemedj.SMJ-2021-438 PMid:36722518 PMCid:PMC9979798 Lin S., Wang C., Li Z., and Qiu X., 2023, Distinct H3K27me3 and H3K27ac modifications in neural tube defects induced by benzo[a]pyrene, Brain Sciences, 13(2): 334. https://doi.org/10.3390/brainsci13020334 PMid:36831877 PMCid:PMC9954656 Liu X., Wang A., Shi Y., Dai M., Liu M., and Cai H., 2023, PROTACs in epigenetic cancer therapy: current status and future opportunities, Molecules, 28(3): 1217. https://doi.org/10.3390/molecules28031217 PMid:36770884 PMCid:PMC9919707 Lordo M., Stiff A., Oakes C., and Mundy-Bosse B., 2023, Effects of epigenetic therapy on natural killer cell function and development in hematologic to anti-PD-1 based immunotherapy, Frontiers in Immunology, 14: 959868. https://doi.org/10.3389/fimmu.2023.959868 malignancy, Journal of Leukocyte Biology, 113(5): 518-524. https://doi.org/10.1093/jleuko/qiad026 PMid:36860165 PMCid:PMC10443672 Luo L.F., Fu S., Du W., He L.N., Zhang X.Y., Wang Y.X., Zhou Y.X., and Hong S.D., 2023, LRRC3B and its promoter hypomethylation status predicts response PMid:36798137 PMCid:PMC9928207 Noguer P., Bermejo A., Mancuso F., Higareda J., López M., Chersicola M., Martínez P., Camino P., Knap P., Zajec V., and Kruusmaa K., 2023, Abstract P028: Methylation biomarkers for colorectal cancer early detection and survival prognostics impact gene expression and link to cancer-related biological pathways, Cancer Prevention Research, 16(1): P028. https://doi.org/10.1158/1940-6215.PrecPrev22-P028 Orlov Y.L., Chen W.L., Sekacheva M.I., Cai G., and Li H., 2022, Editorial: high-throughput sequencing-based investigation of chronic disease markers and mechanisms, Front. Genet., 13: 922206. https://doi.org/10.3389/fgene.2022.922206 PMid:35801080 PMCid:PMC9253685 Ren L.W., Yang Y.H., Li W., Yang H., Zhang Y., Ge B., Zhang S., Du G., and Wang J.H., 2023, Recent advances in epigenetic anticancer therapeutics and future perspectives, Frontiers in Genetics, 13: 1085391. https://doi.org/10.3389/fgene.2022.1085391 PMid:36685834 PMCid:PMC9845602 Ridha I., Xu C., Chung Y., Park J., LaBaer J., and Murugan V., 2023, Multiplexed methylated DNA immunoprecipitation sequencing (Mx-MeDIP-Seq) to study DNA methylation using low amounts of DNA, bioRxiv, 2023: 1. https://doi.org/10.1101/2023.01.09.523163 Sanger F., Nicklen S., and Coulson A.R., 1977, DNA sequencing with chain-terminating inhibitors, Proc Natl Acad Sci. U.S.A., 74(12): 5463-5467. https://doi.org/10.1073/pnas.74.12.5463 PMid:271968 PMCid:PMC431765 Seker Yilmaz B., and Gissen P., 2023, Targeting the liver to treat the eye, EMBO Molecular Medicine, 15(4): e17285. https://doi.org/10.15252/emmm.202217285 PMid:36846970 PMCid:PMC10086576 Selcen I., Prentice E., and Casaccia P., 2023, The epigenetic landscape of oligodendrocyte lineage cells, Annals of the New York Academy of Sciences, 1522(1): 24-41. https://doi.org/10.1111/nyas.14959 PMid:36740586 PMCid:PMC10085863 Shoaib S., Ansari M.A., Ghazwani M., Hani U., Jamous Y.F., Alali Z., Wahab S., Ahmad W., Weir S.A., Alomary M.N., Yusuf N., and Islam N., 2023, Prospective epigenetic actions of organo-sulfur compounds against cancer: perspectives and molecular mechanisms, Cancers, 15(3): 697.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==